- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02841007
Midds Ankle Fracture
April 12, 2017 updated by: Firstkind Ltd
gekoTM Neuromuscular Electrostimulation (NMES) Device, Pilot Feasibility Study Looking at Time to Surgery Study in Patients Requiring Ankle Fixation Following Fracture, Comparison to Matched Retrospective Controls
The geko™ device is indicated for the prevention and treatment of oedema.
The aim of this study is to show that recruiting, and performing study assessments in ankle fracture patients requiring surgery to fix their ankle attending the James Cook Hospital is feasible, and to obtain data to support the powering of a larger study to demonstrate the effectiveness of the geko™ device at reducing length of stay for this population of patients.
This study will also allow us to assess the acceptability, tolerability and compliance of treatment with the geko device.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Middlesbrough, United Kingdom, TS4 3BW
- James Cook Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Aged 18-60 years old
- Clinically and radiologically diagnosed acute ankle fracture that, in the opinion of the treating surgeon, requires operative fixation
- Able to understand the Patient Information Sheet (PIS) and willing to sign the written Informed Consent Form.
- Able and willing to follow the protocol requirements.
Exclusion Criteria:
- Has a pacemaker
- Morbid Obesity (BMI Index >40kg/m2).
- Patients who on presentation to hospital are known to be pregnant.
- Clinically significant co-morbidities that need to be treated prior to surgical intervention and could therefore impact upon time to theatre
- History or signs of previous deep or superficial vein thrombosis/pulmonary embolism.
- Varicosities, ulceration or erosion around the area of the leg where the study device would be fitted
- Diabetic
- Already taking part in a clinical study, or has so within the last 8 weeks
- None responder to geko™ device
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: geko device arm
Patients consenting to take part will receive the geko device prior to surgery to internally fixate their fractured ankle, to reduce and prevent oedema
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Feasibility to recruit n=20 ankle fracture patients in trauma setting within 4 months
Time Frame: 4 months
|
4 months
|
Time to readiness for surgery
Time Frame: 0-~7days
|
0-~7days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Oedema reduction in prospective geko™ subjects prior to surgery, by two circumferential measures using tape measures built into the patients plaster cast
Time Frame: 0-~7days
|
0-~7days
|
Adverse events, including the need for secondary surgery or additional treatment, serious adverse events
Time Frame: study duration up to ~14days
|
study duration up to ~14days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2016
Primary Completion (Actual)
February 1, 2017
Study Completion (Actual)
February 1, 2017
Study Registration Dates
First Submitted
July 15, 2016
First Submitted That Met QC Criteria
July 20, 2016
First Posted (Estimate)
July 21, 2016
Study Record Updates
Last Update Posted (Actual)
April 13, 2017
Last Update Submitted That Met QC Criteria
April 12, 2017
Last Verified
July 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FKD-LOS-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ankle Fracture Requiring Internal Fixation
-
Medical Center HaaglandenLeiden University Medical CenterUnknownTrimalleolar Fracture | Open Reduction and Internal Fixation | Posterior MalleolusNetherlands
-
Medical Center HaaglandenLeiden University Medical CenterUnknownTrimalleolar Fracture | AO Weber C Fractures | Syndesmotic Stability | Open Reduction and Internal FixationNetherlands
-
Rennes University HospitalUnknown
-
Herlev HospitalWithdrawnAnkle Fracture in Need of Surgical Fixation
-
University of CalgaryOrthopaedic Trauma Association; AO North AmericaCompletedFractures, Comminuted | Fracture Fixation, InternalCanada
-
Ross LeightonBiocomposites LtdCompletedTibial Fractures | Intra-Articular Fractures | Fracture Fixation, InternalCanada
-
Hôpital du ValaisUnknownInterest of Navigation for the Treatment of Pertrochanteric Fractures With the Gamma 3 Nail (INOPEG)Femoral Fractures | Trochanteric Fractures | Fracture Fixation, InternalSwitzerland
-
University of ManitobaNot yet recruitingAnesthesia, Local | Metacarpal Fracture | Finger Fracture | Fracture Fixation, Internal | Tendon Injury - Hand
-
Maastricht University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentRecruitingQuality of Life | Lisfranc Fracture | Arthrodesis | Internal FixationNetherlands
-
Peking University Third HospitalRecruitingFemoral Neck Fractures | Internal FixationChina
Clinical Trials on geko neuromuscular electrostimulation device
-
Hampshire Hospitals NHS Foundation TrustFirstkind LtdCompletedVenous Thrombosis | Arthroplasty, Replacement, Hip
-
Firstkind LtdTerminatedLeg Ulcer | Venous Leg Ulcer | Venous UlcerCanada
-
Hamilton Health Sciences CorporationCompleted
-
Firstkind LtdNational Institute for Health Research, United Kingdom; University of California and other collaboratorsRecruitingDeep Vein Thrombosis | Venous Thromboembolism | Stroke, Acute | Pulmonary EmbolismUnited Kingdom
-
Hospital de TerrassaUnknown
-
Firstkind LtdActive, not recruitingDiabetic Foot Ulcer | Venous Leg Ulcer | Wound | Arterial Leg UlcerUnited Kingdom, United States
-
University of Sao Paulo General HospitalRecruitingAtrophy, MuscularBrazil
-
Lawson Health Research InstituteCompletedEdema | Kidney Transplant | Kidney Pancreas TransplantCanada
-
Imperial College LondonCompletedVenous Insufficiency | Chronic Venous Disease | Deep Venous ObstructionUnited Kingdom
-
Firstkind LtdCompletedVenous Leg UlcerUnited Kingdom